Abiomed to Present at the Cowen and Company 35th Annual Health Care Conference
February 25 2015 - 5:08PM
Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough
heart support technologies, today announced that Robert L. Bowen,
Vice President & Chief Financial Officer, will present at the
Cowen and Company 35th Annual Health Care Conference on Wednesday,
March 4, 2015 at 11:20 a.m. EST. The conference will be held at The
Boston Marriott Copley Place Hotel in Boston, MA.
ABOUT ABIOMED
Based in Danvers, Massachusetts, Abiomed, Inc., is a leading
provider of medical devices that provide circulatory
support. Our products are designed to enable the heart to rest
by improving blood flow and/or performing the pumping of the heart.
For additional information please visit: www.abiomed.com
FORWARD-LOOKING STATEMENTS
This release contains forward-looking statements, including
statements regarding development of Abiomed's existing and new
products, the Company's progress toward commercial growth, and
future opportunities and expected regulatory approvals. The
Company's actual results may differ materially from those
anticipated in these forward-looking statements based upon a number
of factors, including uncertainties associated with development,
testing and related regulatory approvals, including the potential
for future losses, complex manufacturing, high quality
requirements, dependence on limited sources of supply, competition,
technological change, government regulation, litigation matters,
future capital needs and uncertainty of additional financing, and
other risks and challenges detailed in the Company's filings with
the Securities and Exchange Commission, including the most recently
filed Annual Report on Form 10-K. Readers are cautioned not to
place undue reliance on any forward-looking statements, which speak
only as of the date of this release. The Company undertakes no
obligation to publicly release the results of any revisions to
these forward-looking statements that may be made to reflect events
or circumstances that occur after the date of this release or to
reflect the occurrence of unanticipated events.
CONTACT: For further information please contact:
Ingrid Goldberg
Director, Investor Relations
978-646-1590
igoldberg@abiomed.com
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Apr 2024 to May 2024
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From May 2023 to May 2024